Your browser doesn't support javascript.
loading
The Influence of an Eight-Week Cycloergometer-Based Cardiac Rehabilitation on Serum Antioxidant Status in Men with Coronary Heart Disease: A Prospective Study.
Gawron-Skarbek, Anna; Chrzczanowicz, Jacek; Kostka, Joanna; Nowak, Dariusz; Drygas, Wojciech; Jegier, Anna; Kostka, Tomasz.
Afiliação
  • Gawron-Skarbek A; Department of Hygiene and Health Promotion, Medical University of Lodz, 90-752 Lodz, Poland. anna.gawron@umed.lodz.pl.
  • Chrzczanowicz J; Cardiac Rehabilitation Centre, Copernicus Memorial Hospital, Lodz, 90-001 Lodz, Poland. jacekchrz@interia.pl.
  • Kostka J; Department of Physical Medicine, Medical University of Lodz, 90-647 Lodz, Poland. joanna.kostka@umed.lodz.pl.
  • Nowak D; Department of Clinical Physiology, Medical University of Lodz, 92-215 Lodz, Poland. dariusz.nowak@umed.lodz.pl.
  • Drygas W; Department of Preventive Medicine, Medical University of Lodz, 90-752 Lodz, Poland. wojciech.drygas@umed.lodz.pl.
  • Jegier A; Department of Sports Medicine, Medical University of Lodz, 92-213 Lodz, Poland. anna.jegier@umed.lodz.pl.
  • Kostka T; Department of Geriatrics, Medical University of Lodz, 90-993 Lodz, Poland. tomasz.kostka@umed.lodz.pl.
Medicina (Kaunas) ; 55(4)2019 Apr 18.
Article em En | MEDLINE | ID: mdl-31003426
Background and objectives: A body of evidence confirms the benefits of cardiac rehabilitation (CR) in coronary heart disease (CHD) patients, but it remains unclear whether it enhances the antioxidant potential. The aim of the study was to assess the influence of an eight-week aerobic cycloergometer-based CR program on serum total antioxidant capacity (TAC) and other CHD risk factors. Materials and Methods: The study involved 36 men with CHD (55.2 ± 9.0 years). TAC was assessed with two methods: ferric reducing ability of serum (TAC-FRAS) and 2.2-diphenyl-1-picryl-hydrazyl (TAC-DPPH). Aerobic capacity was evaluated during a submaximal exercise test. TAC and other anthropometric, biochemical and physical activity/fitness measures were performed twice: before the beginning and after termination of CR. Results: Aerobic capacity was higher (7.0 ± 2.6 vs. 8.0 ± 2.5 MET-metabolic equivalents; p < 0.01), but values of resting diastolic blood pressure were lower (81.9 ± 7.6 vs. 77.4 ± 8.9 mmHg; p < 0.01) after termination of CR. Other classic cardiometabolic, anthropometric, and biochemical measures did not change with CR. No difference in TAC-FRAS was found after CR, whereas TAC-DPPH was significantly lower (16.4 ± 4.0 vs. 13.2 ± 3.7% reduction; p < 0.01). Conclusions: Antioxidant potential measured as TAC-DPPH, but not as TAC-FRAS, decreased with the CR program. The recognized health benefits of CR are not related to augmented serum antioxidant status.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article